Latizolil (Latanoprost)

Latanoprost is a prostaglandin F‑type receptor agonist. By binding to these receptors in the eye, it increases the uveoscleral outflow of aqueous humor, which reduces intraocular pressure and helps control glaucoma and ocular hypertension.

The dosing regimen for Latizolil is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety of Latanoprost in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Latizolil, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Latizolil (Latanoprost) belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intraocular pressure reduction. Compared with beta‑blocker eye drops, prostaglandin analogs often have a more favorable dosing schedule and may cause fewer systemic side effects, though they can cause pigmentary changes in the eye.

Latizolil should be stored at room temperature, below 25 °C. Keep the bottle in its original packaging, protect it from light and moisture, and discard any solution that appears discolored or contaminated.

Latizolil is administered as a topical ophthalmic solution. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a pocket, and place one drop into the eye. Close the eye gently for a few seconds and avoid blinking excessively.

Serious risks include uveitis, severe allergic reactions, and rare cases of intraocular infection (endophthalmitis). Patients should seek immediate medical attention if they experience persistent eye pain, sudden vision loss, or signs of infection such as redness, swelling, or discharge.

Latizolil should not be used by individuals with known hypersensitivity to Latanoprost or any component of the formulation, and it is contraindicated in eyes with active intraocular inflammation or infection. Patients with certain ocular conditions should discuss suitability with their ophthalmologist.